Von Willebrand disease (VWD) is an inherited bleeding disorder caused by a deficiency or dysfunction of von Willebrand factor, an important protein that plays a key role in platelet aggregation and stabilization of coagulation factor VIII. The disorder is characterized by a predisposition to prolonged and extensive bleeding, especially as a result of trauma, surgery, or menstruation. VWD may also cause sinusitis and nosebleeds, which significantly impacts the quality of life of patients. There are three main types of VWD, each with its own clinical manifestations and severity.
History of the disease and interesting historical facts
Von Willebrand disease was first described in 1926 by Finnish physician Erkki Willebrand, who observed serial cases of hemorrhages in patients with similar clinical symptoms. Initially, the disease was considered a rare disorder, but with the development of medicine and hemostasis, it became more widely studied and diagnosed. An interesting fact is that in the 1970s, various types of VWD were identified, which allowed for a more accurate approach to diagnosis and the development of treatment methods. Mistaken identification of VWD as hemophilia significantly complicated diagnosis, since the symptoms of these diseases are similar, however, further research led to a distinction between them and a more accurate definition of pathogenesis.
Epidemiology
The prevalence of von Willebrand disease varies in different populations and regions. According to current data, the prevalence of VWD is from 1 to 2% of the general population. However, many cases remain undiagnosed, which makes it difficult to accurately calculate. Among the types of the disease, type 1 is the most common, while type 2 and type 3 are considered rarer. The most common forms have the same frequency in both men and women, but more severe forms are often detected in women, which is due to the peculiarities of the menstrual cycle. An important part of the epidemiology of VWD is monitoring and diagnosis, since it is important to detect the disease in the early stages to prevent complications associated with injuries and surgical interventions.
Genetic predisposition to this disease
Von Willebrand disease is an inherited disorder that is transmitted in an autosomal dominant manner. This means that one copy of a mutated gene is enough to cause the disease. Specifically, the genes involved include VWF (von Willebrand factor), which is located on chromosome 12. Mutations in this gene can lead to either deficiency of the factor or its dysfunction. There are many types of mutations, such as deletions, insertions, and nucleotide substitutions, that can affect the structure and function of von Willebrand factor. Because of this, genetic testing can be useful in determining the type of disease and its predisposition in the family.
Risk factors for the development of this disease
Risk factors that contribute to the development and severity of von Willebrand disease can be both physical and chemical. Physical factors include:
- Heredity – having relatives with similar symptoms may indicate a risk of the disease.
- Concomitant diseases such as liver failure, diabetes mellitus and others.
Chemical factors may include:
- Use of certain medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs), which may affect platelet aggregation function.
- Exposure to substances that negatively affect the hemostasis system.
It is important to note that women may be more susceptible to developing the disease due to hormonal changes associated with the menstrual cycle and pregnancy.
Diagnosis of this disease
Diagnosis of von Willebrand disease begins with a careful analysis of the medical history and clinical symptoms, such as:
- Frequent nosebleeds;
- Prolonged menstruation;
- Bluebottles without apparent cause;
- Bleeding after surgery.
Laboratory tests are a key step in diagnosing BV. They may include:
- Determination of the level of von Willebrand factor in plasma;
- Factor VIII level test;
- Platelet aggregation tests using ristocetin;
- Genetic testing to detect mutations in the VWF gene.
Radiological examinations such as ultrasound may be used to evaluate internal organs for complications. Differential diagnosis includes ruling out other disorders such as hemophilia and thrombocytopenia that may be the cause of increased bleeding.
Treatment
Treatment for von Willebrand disease is aimed at preventing and controlling bleeding. General treatment may include:
- Lifestyle and dietary changes to improve overall health;
- Avoiding contact with potential traumatic factors;
- Educating patients and their families on symptom management.
Pharmacological treatment may include:
- Desmopressin (DDAVP) to increase levels of factor VIII and von Willebrand factor;
- Blood clotting factors in severe forms of the disease;
- Aggressive measures for severe or life-threatening bleeding.
Surgical treatment may be required in severe cases and is usually performed only under carefully controlled hemostasis. Other treatments may include physical rehabilitation and psychotherapy as needed.
List of medications used to treat this disease
- Desmopresin (DDAVP);
- Coagulation factors VIII;
- Epotenin alpha;
- Tranexamic acid;
- Von Willebrand factor concentrates.
Disease monitoring
Monitoring of patients with von Willebrand disease involves periodic clinical observation and laboratory testing to monitor von Willebrand factor and factor VIII levels. Monitoring steps should take into account:
- Regular tests to determine changes in factor levels;
- Prompt treatment if unusual symptoms occur;
- Discuss all injury cases with a medical professional.
The prognosis for patients with von Willebrand disease is generally good, but there is a risk of blood clots if overtreated, so it is important to maintain a balance. Complications may include severe or life-threatening bleeding, especially after surgery.
Age-related features of the disease
Von Willebrand disease manifests itself at different ages, which requires a special approach to treatment. In infants and children, symptoms may be less pronounced, and diseases are often diagnosed based on family history. In adolescents, worsening symptoms during menstruation are common, and in older people, the presence of concomitant diseases can aggravate the manifestations of the disease. In this regard, the approach to treatment and monitoring of patients must be individualized, taking into account the age characteristics and living conditions of the patient.
Questions and Answers
- What is von Willebrand disease? It is an inherited disorder associated with a deficiency or dysfunction of von Willebrand factor, resulting in an increased tendency to bleed.
- How is von Willebrand disease diagnosed? Diagnosis is based on history, clinical symptoms, laboratory tests of von Willebrand factor and factor VIII levels, and genetic testing.
- How is von Willebrand disease treated? Treatment involves the use of desmopressin, clotting factors, and in some cases surgery to control bleeding.
- What are the risk factors for the disease? The main risk factors are heredity, concomitant diseases and characteristics of the menstrual cycle in women.
- What is the prognosis for patients with von Willebrand disease? The prognosis is usually good, but regular monitoring and following doctor's recommendations are important to prevent complications.
